In February 2016, BCCRIN was repurposed to help establish BC AHSN, with the BC AHSN Board committed to supporting its mandate.
A report was commissioned for the BC AHSN Board to assess BCCRIN’s current state and to provide recommendations. The recommendations from the Board were to:
- In partnership with key BCCRIN stakeholders, facilitate the development of a vision for BC’s clinical research environment;
- As part of that vision, confirm the role, branding, leadership, and resources for BCCRIN as a clinical research unit parallel to the BC SUPPORT Unit within BC AHSN.
In March 2017, BC AHSN/ BC SUPPORT Unit hosted a strategic planning workshop with key stakeholders to collectively develop a vision and offer recommendations to the BC AHSN Board for supporting a thriving clinical research environment that builds on the legacy of BCCRIN. The Board unanimously endorsed a strategic framework and strategy for moving forward.
A project to transition clinical research support functions into BC AHSN is now approved and underway. Overseen by a project steering committee, the Clinical Trials BC Transition Project will be implemented by a working group with input from an advisory committee.
As the project progresses, further decisions will be made regarding the leadership, resources and organizational structures that are needed within the BC AHSN organization to support this key provincial building block.
Transition Project Steering Committee
Deirdre Rogers, Clinical Trials BC